Unmet needs in adult patients with ulcerative colitis in Spain: a real-world Adelphi Disease Specific Programme study
While disease severity appeared to be lower after the initiation of current treatment, and despite the high prevalence of treatment satisfaction, almost a third of patients remained classified as moderate-to-severe, experiencing symptoms, flares, and impaired HRQoL. Therefore, there is a need for new therapeutic alternatives to target patient unmet needs.
Authors
- Theresa Hunter (ORCID: https://orcid.org/0000-0001-8412-9175)
- Hugo Gabilondo
- Sebastián Moyano (ORCID: https://orcid.org/0000-0001-5100-9513)
- Ignacio Marín‐Jiménez (ORCID: https://orcid.org/0000-0001-5424-2484)
- Hannah Knight (ORCID: https://orcid.org/0000-0002-6809-2517)
- Niamh Harvey (ORCID: https://orcid.org/0000-0002-2855-297X)
- Silvia Díaz‐Cerezo (ORCID: https://orcid.org/0000-0001-6351-818X)
- Pilar Nos (ORCID: https://orcid.org/0000-0002-6619-1511)
- Itxaso Aguirregabiria
Institutions
- Hospital General Universitario Gregorio Marañón (ES)
- Hospital Universitari i Politècnic La Fe (ES)
- Adelphi Group (United Kingdom) (GB)
- Eli Lilly (Spain) (ES)
Publication Details
- Journal
- Therapeutic Advances in Gastroenterology
- Published
- 2025-03-30
- DOI
- https://doi.org/10.1177/17562848251325190
- Citations
- 2
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 3.63